Literature DB >> 23553281

Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.

P De Nardo1, A Oliva, M L Giancola, P Ghirga, P Mencarini, M Bibas, E Nicastri, A Antinori, A Corpolongo.   

Abstract

Artemisinin and its derivatives are essential components of artemisinin-based combination therapies for treating severe falciparum malaria. In this paper, we describe the occurrence of haemolysis after oral artemether-lumefantrine treatment. To the best of our knowledge, this is the second reported case of a patient affected by severe falciparum malaria with haemolytic anaemia that is likely associated with oral artemether-lumefantrine treatment.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23553281     DOI： 10.1007/s15010-013-0451-x

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  13 in total

1.  [Severe falciparum malaria with prolonged hemolytic anemia after successful treatment with intravenous artesunate].

Authors:  Ichiro Itoda; Takeshi Yasunami; Ken Kikuchi; Hisashi Yamaura; Kyoichi Totsuka; Kentaro Yoshinaga; Masanao Teramura; Hideaki Mizoguchi; Toshimitsu Hatabu; Shigeyuki Kano
Journal:  Kansenshogaku Zasshi       Date:  2002-08

2.  Severe malaria, artesunate and haemolysis.

Authors:  Pietro Caramello; Rosanna Balbiano; Tiziano De Blasi; Monica Chiriotto; Maura Deagostini; Guido Calleri
Journal:  J Antimicrob Chemother       Date:  2012-04-19       Impact factor: 5.790

Review 3.  Immune hemolytic anemia associated with drug therapy.

Authors:  George Garratty
Journal:  Blood Rev       Date:  2010-07-21       Impact factor: 8.250

4.  Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine.

Authors:  Angela Corpolongo; Pasquale De Nardo; Piero Ghirga; Elisa Gentilotti; Rita Bellagamba; Chiara Tommasi; Maria Grazia Paglia; Emanuele Nicastri; Pasquale Narciso
Journal:  Malar J       Date:  2012-03-27       Impact factor: 2.979

5.  In vitro hemolytic effect of sulfadoxine/pyrimethamine and artemether/lumefantrine on malaria parasitized erythrocytes of female patients.

Authors:  Festus Chinyereugo Anaba; Blessing Osemengbe Ahiante; Dagogo John Pepple
Journal:  Pak J Pharm Sci       Date:  2012-10       Impact factor: 0.684

6.  [A case of falciparum malaria successfully treated with intravenous artesunate].

Authors:  C Yasuoka; A Yasuoka; Y Yamamoto; I Genka; T Hatabu; S Kohno; S Oka; S Kano
Journal:  Kansenshogaku Zasshi       Date:  2001-09

7.  [A case of falciparum malaria successfully treated with intravenous artesunate].

Authors:  Sadako Yoshizawa; Kazuo Hike; Kazuhiro Kimura; Tetsuya Matsumoto; Nobuhiko Furuya; Kazuhiro Tateda; Shigeyuki Kano; Keizo Yamaguchi
Journal:  Kansenshogaku Zasshi       Date:  2002-10

8.  Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.

Authors:  Thierry Rolling; Stefan Schmiedel; Dominic Wichmann; Dieter Wittkopf; Gerd-Dieter Burchard; Jakob P Cramer
Journal:  Malar J       Date:  2012-05-17       Impact factor: 2.979

9.  Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact.

Authors:  Issaka Sagara; Bakary Fofana; Jean Gaudart; Bakary Sidibe; Amadou Togo; Sekou Toure; Kassim Sanogo; Demba Dembele; Alassane Dicko; Roch Giorgi; Ogobara K Doumbo; Abdoulaye A Djimde
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

10.  Intravenous artesunate for severe malaria in travelers, Europe.

Authors:  Thomas Zoller; Thomas Junghanss; Annette Kapaun; Ida Gjorup; Joachim Richter; Mats Hugo-Persson; Kristine Mørch; Behruz Foroutan; Norbert Suttorp; Salih Yürek; Holger Flick
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883
View more
  13 in total

1.  Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.

Authors:  Yasuhiro Tsuchido; Fukumi Nakamura-Uchiyama; Kasumi Toyoda; Moritoshi Iwagami; Kentaro Tochitani; Koh Shinohara; Naokuni Hishiya; Taku Ogawa; Kenji Uno; Kei Kasahara; Yukiteru Ouji; Shigeyuki Kano; Keiichi Mikasa; Tsunehiro Shimizu; Masahide Yoshikawa; Haruhiko Maruyama
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

2.  Case definition: postartemisinin delayed hemolysis.

Authors:  Paul M Arguin
Journal:  Blood       Date:  2014-07-10       Impact factor: 22.113

3.  Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.

Authors:  Yinxian Yang; Hailing Gao; Shuang Zhou; Xiao Kuang; Zhenjie Wang; Hongzhuo Liu; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

4.  Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.

Authors:  Marthe Charles; Jeffery M Patterson; Leyla Asadi; Stan Houston
Journal:  Am J Trop Med Hyg       Date:  2015-08-03       Impact factor: 2.345

5.  Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury.

Authors:  Katherine Plewes; Md Shafiul Haider; Hugh W F Kingston; Tsin W Yeo; Aniruddha Ghose; Md Amir Hossain; Arjen M Dondorp; Gareth D H Turner; Nicholas M Anstey
Journal:  Malar J       Date:  2015-06-18       Impact factor: 2.979

6.  Extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome in severe malaria.

Authors:  Carlos Alves; Jen-Ting Chen; Nina Patel; Darryl Abrams; Paulo Figueiredo; Lurdes Santos; António Sarmento; José Artur Paiva; Matthew Bacchetta; May-Lin Wilgus; Roberto Roncon-Albuquerque; Daniel Brodie
Journal:  Malar J       Date:  2013-08-31       Impact factor: 2.979

7.  Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.

Authors:  Florian Kurth; Tilman Lingscheid; Florian Steiner; Miriam S Stegemann; Sabine Bélard; Nikolai Menner; Peter Pongratz; Johanna Kim; Horst von Bernuth; Beate Mayer; Georg Damm; Daniel Seehofer; Abdulgabar Salama; Norbert Suttorp; Thomas Zoller
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

Review 8.  Evidencing the Role of Erythrocytic Apoptosis in Malarial Anemia.

Authors:  Paulo R R Totino; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Front Cell Infect Microbiol       Date:  2016-12-09       Impact factor: 5.293

9.  Severe malaria in Europe: an 8-year multi-centre observational study.

Authors:  Florian Kurth; Michel Develoux; Matthieu Mechain; Denis Malvy; Jan Clerinx; Spinello Antinori; Ida E Gjørup; Joaquím Gascon; Kristine Mørch; Emanuele Nicastri; Michael Ramharter; Alessandro Bartoloni; Leo Visser; Thierry Rolling; Philipp Zanger; Guido Calleri; Joaquín Salas-Coronas; Henrik Nielsen; Gudrun Just-Nübling; Andreas Neumayr; Anna Hachfeld; Matthias L Schmid; Pietro Antonini; Tilman Lingscheid; Peter Kern; Annette Kapaun; José Saraiva da Cunha; Peter Pongratz; Antoni Soriano-Arandes; Mirjam Schunk; Norbert Suttorp; Christoph Hatz; Thomas Zoller
Journal:  Malar J       Date:  2017-01-31       Impact factor: 2.979

10.  Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.

Authors:  Issaka Sagara; Renaud Piarroux; Abdoulaye Djimde; Roch Giorgi; Kassoum Kayentao; Ogobara K Doumbo; Jean Gaudart
Journal:  Malar J       Date:  2014-09-12       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.